Research output per year
Research output per year
Research activity per year
Bacteria are becoming resistant to antibiotics. A strong potential alternative is bacteriophages -"phages" -viruses that infect bacteria. In collaboration with US/Australian company AmpliPhi Biosciences, I am pursuing the use of phages as a treatment for bacterial infections in a number of important medical settings:
-chronic rhinosinusitis: a human trial of this technology commenced in January 2016, in collaboration with ENT surgeon/scientist Prof. PJ Wormald
-diabetic foot ulcer infections
-nasal Staphylococcus aureus decolonization.
I collaborate with the US Army Medical Research Materiel Command to introduce phages into their Combat Wound Infection Control Program.
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Letter
Research output: Contribution to journal › Letter › peer-review
Research output: Contribution to journal › Letter › peer-review